APN has been shown to exert immune regulatory and anti-inflammatory actions and may thus mitigate the increased risk of cancer development related to states of obesity-induced inflammation [54]. This evidence concerns the gene ANPEP and obesity due to melanocortin 4 receptor deficiency.